Anti-zinc finger, RAN-binding domain containing 1 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project
(www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry.
The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these
protocols and other useful information about Prestige Antibodies and the HPA, visit .
Allgemeine Beschreibung
Zinc finger RANBP2-type containing 1 (ZRANB1) is a deubiquitinase which is part of the OTU family. It possesses an ovarian tumor (OTU) catalytic domain. This 708 amino acid protein consists of three amino-terminal Npl4-like zinc finger (NZF) domains. The ZRANB1 gene is localized on human chromosome 10q26.13.
Biochem/physiol Actions
Zinc finger RANBP2-type containing 1 (ZRANB1) is a positive modulator of Wnt signaling pathways. It hydrolyzes K29- and K33-linked ubiquitin chains.
Anti-zinc finger, RAN-binding domain containing 1 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
